You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Obinutuzumab

Showing 226 - 229 of 229
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin's Lymphoma Trial in Worldwide (Bendamustine, Cyclophosphamide, Doxorubicin)

Completed
  • Non-Hodgkin's Lymphoma
  • Kogarah, New South Wales, Australia
  • +33 more
Nov 3, 2016

Diffuse Large B Cell Lymphoma CD20 Positive Trial in Belgium, France (GA101, Rituximab, Doxorubicin)

Terminated
  • Diffuse Large B Cell Lymphoma CD20 Positive
  • Antwerpen, Belgium
  • +121 more
Mar 6, 2018

Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma Trial in Beijing, Guangzhou, Shanghai

Completed
Has Results
  • Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma
  • Obinutuzumab
  • Beijing, China
  • +3 more
Mar 23, 2016

Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Los angeles, California
  • +70 more
Aug 15, 2014